These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of cephradine and cephalothin in the treatment of urinary tract infections. Caloza DL, Losi MJ, Fields LA. N C Med J; 1977 Oct; 38(10):597-600. PubMed ID: 335255 [No Abstract] [Full Text] [Related]
11. A comparative trial of co-trimoxazole and cephradine in patients with recurrent urinary infections. Copper J, Brumfitt W, Hamilton-Miller JM. J Antimicrob Chemother; 1980 Mar; 6(2):231-9. PubMed ID: 6991469 [No Abstract] [Full Text] [Related]
12. Clinical trial: cephradine in the treatment of urinary tract infection. Butler M. J Ir Med Assoc; 1973 Mar 24; Suppl():13-4. PubMed ID: 4572638 [No Abstract] [Full Text] [Related]
13. [Application of parenteral cephradine in urinary tract infections (author's transl)]. Saito I, Miyamura R, Ban Y, Kawada Y. Jpn J Antibiot; 1976 Nov 24; 29(11):973-8. PubMed ID: 1003682 [Abstract] [Full Text] [Related]
15. A new cephalosporin derivative, cephradine (TM) , in the treatment of acute infective diseases. Limson BM, Siasoco RE, Dial FP. Curr Ther Res Clin Exp; 1972 Mar 24; 14(3):101-6. PubMed ID: 4622888 [No Abstract] [Full Text] [Related]
16. Comparison of cepharadine and cephalexin in the treatment of respiratory and urinary tract infections. Mogabgab WJ. Curr Ther Res Clin Exp; 1976 Apr 24; 19(4):421-32. PubMed ID: 4284 [No Abstract] [Full Text] [Related]
17. Comparison of pivmecillinam and cephradine in bacteriuria in pregnancy and in acute urinary tract infection. Brumfitt W, Franklin I, Hamilton-Miller J, Anderson F. Scand J Infect Dis; 1979 Apr 24; 11(4):275-9. PubMed ID: 231299 [Abstract] [Full Text] [Related]
18. Recurrent urinary infections in women: clinical trial of cephradine as a prophylactic agent. Brumfitt W, Hamilton-Miller JM. Infection; 1987 Apr 24; 15(5):344-7. PubMed ID: 3319912 [Abstract] [Full Text] [Related]
19. Efficacy and tolerability of CGP 9,000 ("Oraspor') in diabetic patients treated for urinary tract infections: a case control study. Kissling M, Xilinas M, Glaus L. Pharmatherapeutica; 1981 Apr 24; 2(9):575-80. PubMed ID: 7267675 [Abstract] [Full Text] [Related]